King’s College London to lead £50m centre for early brain development
A £50 million centre examining how the human brain develops from the womb to early childhood is to be led by King’s College London, working with University College London and the University of Manchester. The new Medical Research Council Centre of Research Excellence for Human Neural Development was announced on 23 October.
The project is intended to address unanswered questions about the earliest stages of brain growth. Its work will focus on the cerebral cortex, a region associated with abilities including language, planning and creativity. The investment is for research into the biological processes that shape development, rather than for a new treatment or clinical service.
Studying development from several directions
The centre plans to bring together three main approaches. Researchers will use imaging to examine the developing brain before and after birth, build laboratory models of brain tissue and use artificial intelligence in the research programme. Combining those methods is intended to connect observations made in babies and children with investigations carried out in the laboratory.
One part of that work will use organoid technology, which creates models of human brain tissue for research. King’s already has a Brain Organoids Laboratory, established with an initial £1.5 million grant in 2024. The new centre is expected to use those models to explore how parts of the brain develop and to investigate the role of particular genes in neurodevelopmental disorders.
Imaging will provide another view of development at stages that are difficult to study directly. The research programme also includes engineering work on technology designed to image brain biology safely and without invasive procedures. That strand will be led from University College London and is intended to examine processes ranging from blood vessels that supply oxygen and nutrients to the activity of cells.
From basic research towards possible clinical use
A central ambition is to identify markers associated with healthy brain development. In time, the centre aims to examine whether such markers can be measured in babies and children and whether they could help researchers develop and evaluate treatments. Those are future research goals, not tests or treatments that are now available to patients.
The programme includes a clinical element involving King’s and the University of Manchester. Professor Tomoki Arichi, a perinatal neuroscientist at King’s and an honorary consultant at Evelina London Children’s Hospital, will work with Professor Shruti Garg, the centre’s clinical lead and deputy director in Manchester. Their collaboration is intended to help assess how findings from laboratory research might eventually be taken into clinical research and care.
Professor Emily Jones at King’s will also follow how newly identified markers of healthy development relate to outcomes beyond infancy. This part of the programme will be based at the Pears Maudsley Centre for Children and Young People. It reflects the long timescale involved in studying early development, where any link between an early measurement and a later outcome needs careful investigation.
What the announcement does and does not establish
The new centre is a significant public research investment, bringing London institutions together with a Manchester partner around a shared programme. It does not report trial results, establish a diagnostic test or show that a particular intervention improves children’s health. Questions about which signals are useful, how consistently they can be measured and whether they can guide care will require further research.
That distinction is especially important in work concerning infants and children. The centre’s purpose is to build a stronger understanding of normal and disrupted early development, then use that knowledge to shape later studies. Any eventual clinical application would need its own evidence and assessment before it could be used in routine care.
For now, the immediate development is the launch of a £50 million partnership with a defined scientific focus. By linking early-life imaging, laboratory models and data-led analysis, the team intends to create a clearer picture of how the brain develops in its first stages and where future research may be most useful.
